Journal Mobile Options
Table of Contents
Vol. 48, Suppl. 1, 1999
Issue release date: October 1999
Gynecol Obstet Invest 1999;48(suppl 1):29–35
(DOI:10.1159/000052866)

Endometriosis and Free Radicals

Ota H. · Igarashi S. · Hatazawa J. · Tanaka T.
aDepartment of Obstetrics and Gynecology, Akita University School of Medicine, Akita and bDepartment of Obstetrics and Gynecology, Koto General Hospital, Hachirogata, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Recent studies have shown that synthase for nitric oxide or scavenger enzymes is distributed throughout the endometrium. We have reported that endothelial nitric oxide synthase, originally identified in vascular endothelial cells, is distributed in glandular epithelial cells in the endometrium, peaking in the midsecretory phase. In addition, it is known that superoxide dismutase is distributed throughout the endometrium, varying with the menstrual cycle. Yet it is not clear how these enzymes are committed in the reproductive processes. Endometriosis is often complicated by infertility and miscarriage. Of particular interest is that these enzymes are overexpressed in the disease throughout the menstrual cycle. These findings strongly suggest that excessive amounts of free radicals are produced in endometriosis. Copyrightz1999S.KargerAG,Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Hasson HM: Incidence of endometriosis in diagnostic laparoscopy. J Reprod Med 1976; 16:135–138.
  2. Drake TS, Grunert GM: The unsuspected pelvic factor in the infertility investigation. Fertil Steril 1980;34:27–31.

    External Resources

  3. Berger GS: Epidemiology of endometriosis; in Nezhat CR, Berger GS, Nezhat FR, Buttram VC Jr, Nezhat CH (eds): Endometriosis. New York, Springer, 1995, pp 1–7.
  4. Metzger DA, Olive DL, Stohs GF, Franklin RR: Association of endometriosis and spontaneous abortion: Effect of control group selection. Fertil Steril 1986;45:18–22.

    External Resources

  5. Daya S: Endometriosis and spontaneous abortion; in Coutinho EM, Spinola P, de Moura LH (eds): Progress in the management of endometriosis. New York, Parthenon, 1995, pp 61–68.
  6. Parazzini F, Vercellin P, Panazza S, Chatenoud L, Oldani S, Crosignani G: Risk factors for adenomyosis. Hum Reprod 1997;12:1275–1279.
  7. Kano T, Furudono M, Nabetani H, Ishii M, Kanda T, Ueki M: The incidence of endometriosis and adenomyosis in patients with habitual abortion in relation to immunological abnormalities (in Japanese). Jpn J Fertil Steril 1997;42:113–118.
  8. Hirata JD, Moghissi KS, Ginsburg KA: Pregnancy after medical therapy of adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril 1993;59:444–445.
  9. Honore LH, Cumming DC, Dunlop DL, Scott JZ: Uterine adenomyoma associated with infertility. A report of three cases. J Reprod Med 1988;33:331–335.

    External Resources

  10. McCarthy S: Magnetic resonance imaging in the evaluation of infertile women. Magn Reson Q 1990;6:239–249.
  11. Woodward PJ, Wagner BJ, Farley TE: MR imaging in the evaluation of female infertility. Radiographics 1993;13:293–310.
  12. Ota H, Maki M, Shidara Y, Kodama H, Takahashi H, Hayakawa M, Fujimori R, Kushima T: Effects of danazol at the immunological level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study. Am J Obstet Gynecol 1992;167:481–486.
  13. Ota H, Igarashi S: HLA-DR expression in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril 1993;60:834–838.
  14. Ota H, Igarashi S, Hayakawa M, Matsui T, Tanaka H, Tanaka T: Effect of danazol on the immunocompetent cells in the eutopic endometrium in patients with endometriosis: a multicenter cooperative study. Fertil Steril 1996;65:545–551.
  15. Ota H, Igarashi S, Tanaka T: Expression of γδT cells and adhesion molecules in endometriotic tissue in patients with endometriosis and adenomyosis. Am J Reprod Immunol 1996;35:477–482.

    External Resources

  16. Ota H, Tanaka T: Integrin adhesion molecules in the endometrial glandular epithelium in patients with endometriosis or adenomyosis. J Obstet Gynaecol Res 1997;23:485–491.
  17. Ota H, Igarashi S, Hatazawa J, Toshinobu T: Distribution of heat shock proteins in eutopic and ectopic endometrium in endometriosis and adenomyosis. Fertil Steril 1997;68:23–28.
  18. Ota H, Igarashi S, Hatazawa J, Tanaka T: Is adenomyosis an immune disease? Hum Reprod Update 1998;4:360–367.
  19. Ota H, Igarashi S, Hatazawa J, Tanaka T: Immune reaction. Understanding endometriosis. New York, Parthenon, 1999, pp 143–148.
  20. Lessey BA, Castelbaum AJ, Sawin SW, Buck CA, Schinnar R, Bilker W, Strom BL: Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994;79:643–649.
  21. Lessey BA, Damjanovich L, Coutifaris C, Castelbaum A, Albelda SM, Buck CA: Integrin adhesion molecules in the human endometrium. Fertil Steril 1992;62:497–506.
  22. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 1994;298:249–258.

    External Resources

  23. Yallampalli C, Byam-Smith M, Sharon MS, Garfield RE: Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 1994;134:1971–1974.
  24. Ignarro LB, Harbison RG, Wood KS, Kadowitz PJ: Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein in stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther 1986;237:893–900.
  25. Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993;169:1316–1320.
  26. Telfer JF, Lyall F, Norman JE, Cameron IT: Identification of nitric oxide synthase in human uterus. Hum Reprod 1995;10:19–23.
  27. Tseng L, Zhang J, Peresleni TYu, Goligorsky MS: Cyclic expression of endothelial nitric oxide synthase mRNA in the epithelial glands of human endometrium. J Soc Gynecol Invest 1996;3:33–38.
  28. Telfer JF, Irvine GA, Kohnen G, Campbell S, Cameron IT: Expression of endothelial and inducible nitric oxide synthase in non-pregnant and decidualised human endometrium. Mol Hum Reprod 1997;3:69–75.
  29. Ota H, Igarashi S, Hatazawa M, Tanaka T: Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril 1998;69:303–308.
  30. Yallampalli C, Garfield RE, Byam-Smith M: Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology 1993;133:1899–1902.
  31. Lyons EA, Taylor PJ, Zheng XH, Ballard G, Levi CS, Kredentser JV: Characterization of subendometrial myometrial contractions throughout the menstrual cycle in normal fertile women. Fertil Steril 1991;55:771–774.
  32. Leyendecker G, Kunz G, Wildt L, Beil D, Deininger H: Uterine hyperperistalsis and dysperistalsis as dysfunctions of the mechanism of rapid sperm transport in patients with endometriosis and infertility. Hum Reprod 1996;7:1542–1551.
  33. Lee QP, Juchau MR: Dysmorphogenic effects of nitric oxide (NO) and NO synthase inhibition: Studies with intra-amniotic injections of sodium nitroprusside and NG- monomethyl-L-arginine. Teratology 1994;49:452–464.

    External Resources

  34. Rao VSN, Chaves MC, Ribeiro RA: Nitric oxide synthase inhibition and the uterotrophic response to oestrogen in immature rats. J Reprod Fertil 1995;105:303–306.
  35. Chaves MC, Ribeiro RA, Rao VSN: Possible involvement of nitric oxide in estrogen-induced uterine edema in the immature rat. Braz J Med Biol Res 1993;26:853–857.
  36. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, Harrison DG: Molecular regulation of the bovine endothelial cell oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol 1995;15:1255–1261.

    External Resources

  37. Mohamed F, Monge JC, Gordon A, Cernacek P, Blais D, Stewart DJ: Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 1995;15:52–57.
  38. Tabibzadeh S: Cytokines and the hypothalamic-pituitary-ovarian endometrial axis. Hum Reprod 1994;9:947–967.
  39. Laloraya M, Pradeep KG, Laloraya MM: Changes in the levels of superoxide anion radical and superoxide dismutase during the estrous cycle of Rattus norvegicus and induction of superoxide dismutase in rat ovary by lutropin. Biochem Biophys Res Commun 1988;57:146–153.
  40. Sato EF, Kobuchi H, Edashige K, Takahashi M, Yoshioka T, Utsumi K, Inoue M: Dynamic aspects of ovarian superoxide dismutase isozymes during the ovulatory process in the rat. FEBS Lett 1992;303:121–125.
  41. Narimoto K, Noda Y, Shiotani M, Tokura T, Goto Y, Takakura K, Mori T, Fujimoto K, Ogawa K: Immunohistochemical assessment of superoxide dismutase expression in the human endometrium throughout the menstrual cycle. Acta Histochem Cytochem 1990;23:487–497.
  42. Sugino N, Shimamura K, Takiguchi S, Tamura H, Ono M, Nakata M, Nakamura Y, Ogino K, Uda T, Kato H: Changes in activity of superoxide dismutase in the human endometrium throughout the menstrual cycle and in early pregnancy. Hum Reprod 1996;11:1073–1078.
  43. Mastroianni L Jr, Jones R: Oxygen tension within the rabbit fallopian tube. J Reprod Fertil 1965;9:99–102.
  44. Narimoto K, Noda Y, Shiotani M, Natsuyama S, Mori T, Fujimoto K, Ogawa K, Kim YC: Role of superoxide dismutase in the fallopian tube function: Immunohistochemical assessment of superoxide dismutase in the fallopian tube. Acta Histochem Cytochem 1991;24:85–91.
  45. Yanagimachi R, Chang MC: In vitro fertilization of golden hamster ova. J Exp Zool 1964;156:361–376.
  46. Whiten WK: Culture of tubal ova. Nature 1957;179:1081–1082.
  47. Noda Y, Matsumoto H, Umaoka Y, Tatsumi K, Kishi J, Mori T: Involvement of superoxide radicals in the mouse two-cell block. Mol Reprod Dev 1991;28:356–360.
  48. Ota H, Igarashi S, Hatazawa J, Tanaka T: Immunohistochemical assessment of superoxide dismutase expression in the endometrium in endometriosis and adenomyosis. Fertil Steril 1999;69:303–308.
  49. Ishikawa M, Nakata T, Yaginuma Y, Nishiwaki K, Goishi K, Saitoh S: Expression of superoxide dismutase (SOD) in adenomyosis. Am J Obstet Gynecol 1993;169:730–734.
  50. Padmaja S, Huie RE: The reaction of nitric oxide with organic peroxyl radicals. Biochem Biophys Res Commun 1993;195:539–544.
  51. Arici A, Oral E: The peritoneal environment in endometriosis; in Diamond MP, Osteen KG (eds): Endometrium and Endometriosis. Malden, Blackwell Science, 1997, pp 161–173.
  52. Wong GHW, Goeddel DV: Induction of manganous superoxide dismutase by tumour necrosis factor: Possible protective mechanisms. Science 1988;242:941–944.
  53. Ono M, Kohda H, Kawaguchi T, Ohhira M, Sekiya C, Namiki M, Takeyasu A, Taniguchi N: Induction of Mn-superoxide dismutase by tumor necrosis factor, interleukin-1 and interleukin-6 in human hepatoma cells. Biochem Biophys Res Commun 1992;182:1100–1107.

    External Resources

  54. Biswas S, Kabir SN, Pal AK: The role of nitric oxide in the process of implantation in rats. J Reprod Fertil 1998;114:157–161.
  55. Ota H, Igarashi S, Hatazawa M, Tanaka T: Significance of optimal levels of nitric oxide in fecundity in mice (in Japanese). Endometriosis Kenkyukaishi 1998;19:107–110.
  56. Chwalisz K, Winterhager E, Thienel T, Garfield RE: Synergistic role of nitric oxide and progesterone during the establishment of pregnancy in the rat. Hum Reprod 1999;14:542–552.

    External Resources



Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50